Testing effectiveness (Phase 2)Study completedNCT01670500What this trial is testingCisplatin vs. Doxorubicin/Cyclophosphamide in BrCaWho this might be right forBreast Cancer Beth Israel Deaconess Medical Center 118
Early research (Phase 1)Looking for participantsNCT04890613What this trial is testingStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationWho this might be right forAdvanced Solid Tumor Senhwa Biosciences, Inc. 52
Testing effectiveness (Phase 2)Ended earlyNCT03140670What this trial is testingMaintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based TherapyWho this might be right forPancreatic Cancer Abramson Cancer Center at Penn Medicine 46
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Testing effectiveness (Phase 2)Looking for participantsNCT05485766What this trial is testingNovel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerWho this might be right forTriple Negative Breast NeoplasmsTriple Negative Breast CancerBreast Neoplasms+5 more Okayama University 23
Not applicableStudy completedNCT04683068What this trial is testingPromoting Men's Adherence to BRCA1/2 Germline Genetic TestingWho this might be right forBRCA1 MutationBRCA2 MutationPsychosocial Factors European Institute of Oncology 264
Not applicableStudy completedNCT02557776What this trial is testingWritten Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast CancerWho this might be right forHereditary Breast Cancer Lund University 542
Testing effectiveness (Phase 2)Active Not RecruitingNCT03344965What this trial is testingOlaparib In Metastatic Breast CancerWho this might be right forMetastatic Breast CancerInvasive Breast CancerSomatic Mutation Breast Cancer (BRCA1)+7 more Beth Israel Deaconess Medical Center 114
Large-scale testing (Phase 3)Looking for participantsNCT02000089What this trial is testingThe Cancer of the Pancreas Screening-5 CAPS5)StudyWho this might be right forPancreas CancerPeutz-Jeghers Syndrome (PJS)Gene Mutation+2 more Johns Hopkins University 9,000
Large-scale testing (Phase 3)Study completedNCT01945775What this trial is testingA Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)Who this might be right forBreast NeoplasmsBRCA 1 Gene MutationBRCA 2 Gene Mutation Pfizer 431
Testing effectiveness (Phase 2)Active Not RecruitingNCT04584255What this trial is testingNiraparib + Dostarlimab In BRCA Mutated Breast CancerWho this might be right forStage I Breast CancerStage II Breast CancerStage III Breast Cancer+5 more Dana-Farber Cancer Institute 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286687What this trial is testingTalazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA GenesWho this might be right forAdvanced Malignant NeoplasmATM Gene MutationBRCA1 Gene Mutation+5 more M.D. Anderson Cancer Center 150
Not applicableStudy completedNCT03075735What this trial is testingProspective Multicentre Cohort Study PROREPAIR-B (mCRPC)Who this might be right forProstate Cancer Centro Nacional de Investigaciones Oncologicas CARLOS III 408